During the past decade, Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin" #1 collaborator was "University of Ulm" with 2 trials as a collaborator, "Zentrum für Klinische Studien Ulm" with 2 trials as a collaborator, "Bayer Healthcare LTD" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Celltrion Healthcare Co., LTD" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin" are "CD20+ Aggressive B-Cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials), "Marginal Zone Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin" in a lesser frequency.

Most popular intervention types in "Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Bendamustine" (2 trials), "Cyclophosphamide" (2 trials), "Obinutuzumab" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd, Zentrum für Innere Medizin, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".